Company Filing History:
2 out of 319 
1 out of 21 
1 out of 1 Years Active: 1997-1999
Title: The Innovative Contributions of Eduardo Luis Setti
Introduction
Eduardo Luis Setti is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance the effectiveness of antibiotics. With a total of 2 patents, Setti's work has garnered attention in the scientific community.
Latest Patents
Setti's latest patents include innovative compounds that serve as potent beta-lactamase inhibitors. One of his notable inventions is the "2-oxo-1-azetidine sulfonic acid derivatives," which is designed to combat antibiotic resistance. This compound features a formula where R1 is selected from a diverse group of chemical structures, including 2-thienyl and 2-furyl. Another significant patent is for "Penam sulfones," which are novel compounds that enhance the effectiveness of beta-lactam antibiotics when used in combination.
Career Highlights
Throughout his career, Setti has worked with prominent companies in the pharmaceutical industry. He has been associated with Taiho Pharmaceutical Company Limited and Synphar Laboratories, Inc. His work in these organizations has allowed him to contribute to the advancement of medical science and the development of new therapeutic agents.
Collaborations
Setti has collaborated with esteemed colleagues, including Samarendra N Maiti and Oludotun A Phillips. These partnerships have facilitated the exchange of ideas and expertise, further enriching his contributions to the field.
Conclusion
Eduardo Luis Setti's innovative work in pharmaceuticals has led to the development of important compounds that address antibiotic resistance. His patents reflect a commitment to enhancing medical treatments and improving patient outcomes. Setti's contributions continue to influence the pharmaceutical landscape positively.